88 related articles for article (PubMed ID: 999061)
1. IgE levels in Hodgkin's disease.
Thomas MR; Steinberg P; Votaw ML; Bayne NK
Ann Allergy; 1976 Dec; 37(6):416-9. PubMed ID: 999061
[TBL] [Abstract][Full Text] [Related]
2. Increased serum IgE in Hodgkin's disease is of polyclonal origin.
Landaas TO; Grimmer O; Heier HE; Godal T
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):377-80. PubMed ID: 121023
[TBL] [Abstract][Full Text] [Related]
3. Alterations of IgE immunoglobulin concentration in the serum after megavoltage radiotherapy with large-field technique in patients with Hodgkin's disease.
Krüsmann W; Slanina J; Nolte I
Strahlenther Onkol; 1990 Apr; 166(4):265-70. PubMed ID: 2109876
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of IgE in malignant lymphogranulomatosis.
Powiertowska-Rezmer M; Rechowicz K; Rostkowska J; Snigurowicz J
Arch Immunol Ther Exp (Warsz); 1977; 25(1):101-6. PubMed ID: 301733
[TBL] [Abstract][Full Text] [Related]
5. [Clincal study on serum immunoglobulin E (IgE) concentrations in patients with malignant lymphoma with special reference to Hodgkin's disease (author's transl)].
Kimura I; Onoshi T; Tanizaki Y; Ueda N
Rinsho Ketsueki; 1975 Dec; 16(12):1117-23. PubMed ID: 1240980
[No Abstract] [Full Text] [Related]
6. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
7. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
Bockman RS
J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
[TBL] [Abstract][Full Text] [Related]
8. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
9. The distinction of Hodgkin's disease from B cell lymphoma.
Warnke RA
Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
11. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
12. The changing trends of adult Hodgkin's disease in Saudi Arabia.
Al-Diab AI; Siddiqui N; Sogiawalla FF; Fawzy EM
Saudi Med J; 2003 Jun; 24(6):617-22. PubMed ID: 12847590
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
Pinkus GS; Said JW
Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum total IgE and cell-mediated immunity in patients with Hodgkin's disease.
Rubinstein E; Sokal JE; Reisman RE; Arbesman CE
Int Arch Allergy Appl Immunol; 1977; 55(1-6):439-43. PubMed ID: 591107
[TBL] [Abstract][Full Text] [Related]
17. Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas.
Amlot PL; Green LA
Br Med J; 1978 Feb; 1(6109):327-9. PubMed ID: 623979
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
19. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
20. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
